T102C

Analytical Considerations for Low Dose DAI Studies

Date
September 10, 2020

Speaker

Speaker Image for Dan Boisvert
Pfizer, Inc.

Related Products

Thumbnail for Midwest Regional Forum 2020 - Day 2
Thumbnail for Analytical Considerations for Low Dose DAI Studies
Analytical Considerations for Low Dose DAI Studies
Dosage Administration Instructions are required prior to clinical dosing throughout a product lifecycle…
Thumbnail for Panel and Q&A

Copyright © 2025 Sharing Science Solutions
Powered by Conexiant DXP